(CNN) - Patients in the United States can now get the popular diabetes and weight loss drug Ozempic for half the price. Novo ...

Women between the ages of 50 and 64 use medications the most. Nearly 12% of people in the United States have taken GLP-1 medications for weight loss, with usage especially common among women ages 50 ...

(Reuters) -Novo Nordisk said on Monday it was offering its diabetes drug Ozempic for $499 per month to eligible cash-paying ...

FDA has approved Novo Nordisk's Wegovy, one-weekly 2.4 mg semaglutide injection for treating metabolic-associated ...

The maker of Ozempic is cutting the price of the drug nearly in half for some patients. Novo Nordisk had already cut the ...

The weight loss injectable Ozempic has faced several lawsuits in 2025 from people who had a negative experience with the ...

New studies link Ozempic and Wegovy to rare vision loss, but experts say the risk is quite small. Here’s what you need to ...

According to NPR, doctors and patients alike have noted the drug has appeared to reduce some people's cravings for booze, ...

GLP-1 drugs suppress appetite and have been shown to reduce calorie intake by up to 800 calories per person per day. GLP-1 ...

The Food and Drug Administration approved the weight loss drug Wegovy to treat an increasingly prevalent liver disease on ...

Cash-paying type 2 diabetes patients in the United States can now access Novo Nordisk's Ozempic for $499 per month through ...